-
Chemotherapy Device for Imatinib Drug Monitoring
Background - The effectiveness of many anticancer drugs varies greatly from patient to patient, with risks of incorrect dosages and adverse side ef...
-
Anti-Cancer Efficient and Non-Toxic Palladium Compounds
Background - Platinum-based antineoplastic drugs have been used since the late 1970s, although they sometimes show significant nephro- and neurotox...
-
Bicyclic Peptide Inhibitors of the Human Urokinase-Type Plasminogen Activator (HUPA)
Background - Bicyclic peptides are small polypeptides that exhibit properties typical of both monoclonal antibodies (high target specificity and af...
-
Dynamics of a "Healthy" Viable Microbiome to Prevent Diseases
Background - Research at Ca Foscari Venice University is focused on understanding what constitutes a “healthy” microbiome in terms of composition,...
-
Reversible Monoacylglycerol Lipase (MAGL) Inhibitors for Neurodegenerative Pathologies and Tumour Treatment
Background - The enzyme monoacylglycerol lipase (MAGL), which is part of the endocannabinoid system (ECS), has therapeutic potential for the treatm...
-
Less Toxic Chemotherapy with Palladium
Background - Targeted, efficient and non-toxic anti-cancer drugs: a new class of palladium compounds could be used as innovative chemotherapeutic m...
-
Copper Compounds for the Treatment of Ovarian Cancer
Background - The present invention is a nanomaterial containing a pharmaceutical composition based on copper (II) nitroprusside (CuNP) for use in...